{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T11:19:43Z","timestamp":1762341583355,"version":"3.40.5"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T00:00:00Z","timestamp":1607904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Catecholaminergic polymorphic ventricular tachycardia (CPVT) is a severe inherited arrhythmic disease associated with a risk of syncope and sudden cardiac death (SCD).<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Aims<\/jats:title>\n<jats:p>We aimed at identifying <jats:italic>RYR2<\/jats:italic> P2328S founder mutation carriers and describing the clinical course associated with the mutation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>The study population was drawn from the Finnish Inherited Cardiac Disorder Research Registry, and from the present genealogical study. Kaplan-Meier graphs, log-rank test and Cox regression model were used to evaluate the clinical course.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>Genealogical study revealed a common ancestor couple living in the late 17<jats:sup>th<\/jats:sup> century. A total of 1837 living descendants were tested for <jats:italic>RYR2<\/jats:italic> P2328S mutation unveiling 62 mutation carriers aged mean 39\u00b123 years old. No arrhythmic deaths were documented among genotyped subjects, but 11 SCDs were detected in non-genotyped family members since 1970. Three genotyped patients (5%) suffered an aborted cardiac arrest (ACA), and 15 (25%) had a syncope triggered by exercise or stress. Rate of cardiac events was higher among patients who in exercise stress test showed a maximum rate of premature ventricular contractions &gt;30\/min (68% vs 17%, p&lt;0.01; hazard ratio = 7.1, p = 0.02), in comparison to patients without the respective finding. A cardioverter-defibrillator (ICD) was implanted to 13 (22%) patients, with an appropriate ICD shock in four (31%) subjects. All ICD shocks, one ACA, and one syncope occurred during \u03b2-blocker medication.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Previously undiagnosed CPVT patients may be identified by well-conducted genealogical studies. The <jats:italic>RYR2<\/jats:italic> P2328S mutation causes a potentially severe phenotype, but its expression is variable, thus calling for additional studies on modifying factors.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0243649","type":"journal-article","created":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T18:42:42Z","timestamp":1607971362000},"page":"e0243649","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1757-7386","authenticated-orcid":true,"given":"Mikael","family":"Koponen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annukka","family":"Marjamaa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6538-635X","authenticated-orcid":true,"given":"Annukka M.","family":"Tuiskula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matti","family":"Viitasalo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terhi","family":"Nallinmaa-Luoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaakko T.","family":"Leinonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Widen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri","family":"Toivonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimmo","family":"Kontula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heikki","family":"Swan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,12,14]]},"reference":[{"key":"pone.0243649.ref001","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/hrt.37.3.339","article-title":"R. Bidirectional tachycardia in a child. A study using his bundle electrography","volume":"37","author":"DT Reid","year":"1975","journal-title":"Br Heart J"},{"key":"pone.0243649.ref002","first-page":"28","article-title":"Catecholaminergic-induced severe ventricular arrhythmias with adams-stokes syndrome in children: report of four cases","volume":"40","author":"P Coumel","year":"1978","journal-title":"Br Heart J"},{"key":"pone.0243649.ref003","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1161\/01.CIR.91.5.1512","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients","volume":"91","author":"A Leenhardt","year":"1995","journal-title":"Circulation"},{"key":"pone.0243649.ref004","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1253\/circj.CJ-16-0326","article-title":"Catecholaminergic Polymorphic Ventricular Tachycardia.","volume":"80","author":"KV Lieve","year":"2016","journal-title":"Circ J."},{"key":"pone.0243649.ref005","doi-asserted-by":"crossref","first-page":"e12512","DOI":"10.1111\/anec.12512","article-title":"Catecholaminergic polymorphic ventricular tachycardia, an update.","volume":"23","author":"AR Perez-Riera","year":"2018","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"pone.0243649.ref006","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrcardio.2012.93","article-title":"Inherited calcium channelopathies in the pathophysiology of arrhythmias.","volume":"9","author":"L Venetucci","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"pone.0243649.ref007","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1016\/S0735-1097(99)00461-1","article-title":"Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts","volume":"34","author":"H Swan","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"pone.0243649.ref008","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/01.CIR.103.4.485","article-title":"Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.","volume":"103","author":"PJ Laitinen","year":"2001","journal-title":"Circulation"},{"key":"pone.0243649.ref009","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/01.CIR.103.2.196","article-title":"Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia.","volume":"103","author":"SG Priori","year":"2001","journal-title":"Circulation"},{"key":"pone.0243649.ref010","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"M Hayashi","year":"2009","journal-title":"Circulation"},{"key":"pone.0243649.ref011","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/europace\/eus031","article-title":"The role of stress test for predicting genetic mutations and future cardiac events in asymptomatic relatives of catecholaminergic polymorphic ventricular tachycardia probands.","volume":"14","author":"M Hayashi","year":"2012","journal-title":"Europace"},{"key":"pone.0243649.ref012","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.jacc.2011.01.026","article-title":"Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"57","author":"C van der Werf","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"pone.0243649.ref013","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives","volume":"5","author":"C van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"pone.0243649.ref014","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial","volume":"2","author":"PJ Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"pone.0243649.ref015","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC).","volume":"36","author":"SG Priori","year":"2015","journal-title":"Eur Heart J"},{"key":"pone.0243649.ref016","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/europace\/eur277","article-title":"Therapeutic approach for patients with catecholaminergic polymorphic ventricular tachycardia: state of the art and future developments.","volume":"14","author":"C van der Werf","year":"2012","journal-title":"Europace"},{"key":"pone.0243649.ref017","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.CIR.0000020013.73106.D8","article-title":"Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia","volume":"106","author":"SG Priori","year":"2002","journal-title":"Circulation"},{"key":"pone.0243649.ref018","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1161\/01.CIR.0000132472.98675.EC","article-title":"Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak.","volume":"109","author":"SE Lehnart","year":"2004","journal-title":"Circulation"},{"key":"pone.0243649.ref019","doi-asserted-by":"crossref","first-page":"e44660","DOI":"10.1371\/journal.pone.0044660","article-title":"Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations","volume":"7","author":"K Kujala","year":"2012","journal-title":"PLoS One"},{"key":"pone.0243649.ref020","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/gut.52.5.647","article-title":"Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia","volume":"52","author":"M Kuokkanen","year":"2003","journal-title":"Gut"},{"key":"pone.0243649.ref021","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1086\/519795","article-title":"PLINK: a tool set for whole-genome association and population-based linkage analyses","volume":"81","author":"S Purcell","year":"2007","journal-title":"Am J Hum Genet"},{"key":"pone.0243649.ref022","doi-asserted-by":"crossref","first-page":"e0125366","DOI":"10.1371\/journal.pone.0125366","article-title":"Antiarrhythmic Effects of Dantrolene in Patients with Catecholaminergic Polymorphic Ventricular Tachycardia and Replication of the Responses Using iPSC Models.","volume":"10","author":"K Penttinen","year":"2015","journal-title":"PLoS One."},{"key":"pone.0243649.ref023","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1093\/europace\/euv380","article-title":"Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography.","volume":"18","author":"J Paavola","year":"2016","journal-title":"Europace"},{"key":"pone.0243649.ref024","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/eurheartj\/ehl543","article-title":"Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves","volume":"28","author":"J Paavola","year":"2007","journal-title":"Eur Heart J"},{"key":"pone.0243649.ref025","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.hrthm.2008.06.011","article-title":"U-waves and T-wave peak to T-wave end intervals in patients with catecholaminergic polymorphic ventricular tachycardia, effects of beta-blockers","volume":"5","author":"M Viitasalo","year":"2008","journal-title":"Heart Rhythm"},{"key":"pone.0243649.ref026","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/cvr\/cvq229","article-title":"Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts.","volume":"89","author":"Y Zhang","year":"2011","journal-title":"Cardiovasc Res"},{"key":"pone.0243649.ref027","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1016\/j.hrthm.2015.03.033","article-title":"Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia","volume":"12","author":"F Wanguemert","year":"2015","journal-title":"Heart Rhythm"},{"key":"pone.0243649.ref028","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry.","volume":"8","author":"TM Roston","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"pone.0243649.ref029","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","article-title":"Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent","volume":"14","author":"MJ Ackerman","year":"2017","journal-title":"Heart Rhythm"},{"key":"pone.0243649.ref030","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2015.09.029","article-title":"Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with beta1-selective beta-blockers in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"IS Leren","year":"2016","journal-title":"Heart Rhythm"},{"key":"pone.0243649.ref031","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review","volume":"15","author":"TM Roston","year":"2018","journal-title":"Heart Rhythm"},{"key":"pone.0243649.ref032","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1093\/eurheartj\/ehz309","article-title":"Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest","volume":"40","author":"C van der Werf","year":"2019","journal-title":"Eur Heart J"},{"key":"pone.0243649.ref033","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.hrthm.2006.08.018","article-title":"Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia","volume":"3","author":"U Mohamed","year":"2006","journal-title":"Heart Rhythm"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243649","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,14]],"date-time":"2020-12-14T18:42:49Z","timestamp":1607971369000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0243649"}},"subtitle":[],"editor":[{"given":"Tomohiko","family":"Ai","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,12,14]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0243649","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,12,14]]}}}